PLSE
Pulse Biosciences Inc
NASDAQ · Health Care
$20.75
+7.06 (+51.57%)
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 764.03M | 720.89M | 620.86M |
| Net Income | 47.13M | 60.22M | 48.91M |
| EPS | — | — | — |
| Profit Margin | 6.2% | 8.4% | 7.9% |
| Rev Growth | +3.6% | -7.3% | +13.8% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 258.69M | 308.01M | 262.97M |
| Total Equity | 758.74M | 738.41M | 772.91M |
| D/E Ratio | 0.34 | 0.42 | 0.34 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | 81.08M | 74.89M | 60.65M |
| Free Cash Flow | 70.58M | 49.96M | 50.83M |